Loading clinical trials...
Loading clinical trials...
Real-world SARS-CoV-2 Antibody Response in Children Aged 5-11 Years Following BNT162b2 mRNA Vaccination Against COVID-19: a Prospective Cohort Study
Conditions
Locations
1
Israel
Schneider Children's Medical Center
Petah Tikva, Israel
Start Date
January 10, 2022
Primary Completion Date
June 30, 2022
Completion Date
June 30, 2022
Last Updated
January 28, 2022
NCT05553743
NCT05556720
NCT05188469
NCT04830800
NCT06646744
NCT06597370
Lead Sponsor
Rabin Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions